Abgenix, Amgen stock up on successful cancer treatment test
3rd Nov 2005, 22:45 GMT
Abgenix Inc. and Amgen Inc. stock rose Thursday after they announced the successful completion of a cancer drug test.
Abgenix, Amgen stock up on successful cancer treatment test related news:
- Abgenix, Amgen cancer treatment test successful — bizjournals.com Health Care:Pharmaceuticals headlines
- Abgenix-Amgen cancer drug gets favorable test result — SacBee -- Business
- Abgenix shares jump on cancer drug results — Latest news from East Bay Business Times
- Experimental cancer drug results sends biotech companies' stocks soaring — SacBee -- Business
- Abgenix shares rally cancer drug's Phase III data — MarketWatch.com - Top Stories
- Amgen, Abgenix Shares Rise on Trial News — WTOP Radio - Business News
- Colon-cancer drug success — RSS Top Stories -- SiliconValley.com
- Media Notification/Webcast Notification - Amgen and Abgenix to Conduct Conference Call and Webcast Regarding Panitumumab Pivotal Study Results - 11/3/2005, — Operations-Related News from StratCenter.com
- Amgen: Krebstherapie erfüllt primäres Endziel in Phase III — Finanztreff.de / BRANCHEN
- Experimental drug slows tumor growth (Reuters) — Yahoo! News: Most Recommended
Latest news from bizjournals.com Health Care:Pharmaceuticals headlines:
- Spectrum Pharmaceuticals gets $5M milestone payment, settles with GlaxoSmithKline
- Corautus Genetics chips at Q3 loss
- Spherix hoping to brush its sweet tooth
- Auxilium added to NASDAQ's biotech index
- CombinatoRx reports revenue boost
- Alexion gets fast-track FDA review for drug Soliris
- InnoCentive identifies a new CEO
- Digene names new CEO
- Dynamic Health dips into the red
- Sigma-Aldrich elects Paul to board